BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1493472)

  • 1. Inhibitory anti-tumor effects of interleukin-4 on Philadelphia chromosome-positive acute lymphocytic leukemia and other hematopoietic malignancies.
    Okabe M; Saiki I; Miyazaki T
    Leuk Lymphoma; 1992 Sep; 8(1-2):57-63. PubMed ID: 1493472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effect of interleukin-4 on the in vitro growth of Ph1-positive acute lymphoblastic leukemia cells.
    Okabe M; Kuni-eda Y; Sugiwura T; Tanaka M; Miyagishima T; Saiki I; Minagawa T; Kurosawa M; Itaya T; Miyazaki T
    Blood; 1991 Sep; 78(6):1574-80. PubMed ID: 1884023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of granulocyte-macrophage colony-stimulating factor in Philadelphia (Ph1)-positive acute lymphoblastic leukemia: studies on two newly established Ph1-positive acute lymphoblastic leukemia cell lines (Z-119 and Z-181).
    Estrov Z; Talpaz M; Zipf TF; Kantarjian HM; Ku S; Ouspenskaia MV; Hirsch-Ginsberg C; Huh Y; Yee G; Kurzrock R
    J Cell Physiol; 1996 Mar; 166(3):618-30. PubMed ID: 8600166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The cellular and molecular-biological studies on Philadelphia chromosome-positive acute lymphocytic leukemia].
    Kunieda Y
    Hokkaido Igaku Zasshi; 1993 May; 68(3):337-49. PubMed ID: 8319933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCR/ABL oncoprotein-targeted antitumor activity of antisense oligodeoxynucleotides complementary to bcr/abl mRNA and herbimycin A, an antagonist of protein tyrosine kinase: inhibitory effects on in vitro growth of Ph1-positive leukemia cells and BCR/ABL oncoprotein-associated transformed cells.
    Okabe M; Kunieda Y; Miyagishima T; Kobayashi M; Kurosawa M; Itaya T; Sakurada K; Miyazaki T
    Leuk Lymphoma; 1993 Jul; 10(4-5):307-16. PubMed ID: 7693103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant human interleukin-4 inhibits growth of some human lung tumor cell lines in vitro and in vivo.
    Topp MS; Koenigsmann M; Mire-Sluis A; Oberberg D; Eitelbach F; von Marschall Z; Notter M; Reufi B; Stein H; Thiel E
    Blood; 1993 Nov; 82(9):2837-44. PubMed ID: 8219232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective inhibition of cell proliferation and BCR-ABL phosphorylation in acute lymphoblastic leukemia cells expressing Mr 190,000 BCR-ABL protein by a tyrosine kinase inhibitor (CGP-57148).
    Beran M; Cao X; Estrov Z; Jeha S; Jin G; O'Brien S; Talpaz M; Arlinghaus RB; Lydon NB; Kantarjian H
    Clin Cancer Res; 1998 Jul; 4(7):1661-72. PubMed ID: 9676840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Lestingi TM; Hooberman AL
    Hematol Oncol Clin North Am; 1993 Feb; 7(1):161-75. PubMed ID: 8449857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
    Steinberg M
    Clin Ther; 2007 Nov; 29(11):2289-308. PubMed ID: 18158072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Philadelphia chromosome-positive Acute Lymphoblastic Leukemia.
    Forghieri F; Luppi M; Potenza L
    Hematology; 2015 Dec; 20(10):618-9. PubMed ID: 26574786
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular and biologic characterization of a newly established Philadelphia-positive acute lymphoblastic leukemia cell line (Z-33) with an autocrine response to GM-CSF.
    Estrov Z; Talpaz M; Ku S; Harris D; LaPushin R; Koller CA; Hirsh-Ginsberg C; Huh Y; Yee G; Kurzrock R
    Leukemia; 1996 Sep; 10(9):1534-43. PubMed ID: 8751477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukemia inhibitory factor in long-term adherent layer cultures: increased levels of bioactive protein in leukemia and modulation by IL-4, IL-1 beta, and TNF-alpha.
    Wetzler M; Estrov Z; Talpaz M; Kim KJ; Alphonso M; Srinivasan R; Kurzrock R
    Cancer Res; 1994 Apr; 54(7):1837-42. PubMed ID: 8137298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the antitumor activity of human IL-4 by in vitro and in vivo assays.
    Wang T; Chen W
    Chin Med Sci J; 1994 Dec; 9(4):248-54. PubMed ID: 7718866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel monoclonal antibody, KOR-SA3544 which reacts to Philadelphia chromosome-positive acute lymphoblastic leukemia cells with high sensitivity.
    Mori T; Sugita K; Suzuki T; Okazaki T; Manabe A; Hosoya R; Mizutani S; Kinoshita A; Nakazawa S
    Leukemia; 1995 Jul; 9(7):1233-9. PubMed ID: 7543176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia.
    Brissot E; Labopin M; Beckers MM; Socié G; Rambaldi A; Volin L; Finke J; Lenhoff S; Kröger N; Ossenkoppele GJ; Craddock CF; Yakoub-Agha I; Gürman G; Russell NH; Aljurf M; Potter MN; Nagler A; Ottmann O; Cornelissen JJ; Esteve J; Mohty M
    Haematologica; 2015 Mar; 100(3):392-9. PubMed ID: 25527562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Fielding AK
    Hematology Am Soc Hematol Educ Program; 2011; 2011():231-7. PubMed ID: 22160039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment and characterization of a new Ph1-positive ALL cell line (ALL/MIK) presenting bcr gene rearrangement on bcr-2 and ALL-type bcr/abl transcript: suggestion of in vitro differentiation to monocytoid lineage.
    Higa T; Okabe M; Kunieda Y; Kodama S; Itaya T; Kurosawa M; Sakurada K; Maekawa I; Shoji M; Kasai M
    Leuk Lymphoma; 1994 Jan; 12(3-4):287-96. PubMed ID: 8167560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Philadelphia-positive Acute Lymphoblastic Leukemia: Do We Still Need Allogeneic Transplantation? Argument "Pro".
    Bachanova V
    Clin Lymphoma Myeloma Leuk; 2017 Jul; 17S():S10-S15. PubMed ID: 28760293
    [No Abstract]   [Full Text] [Related]  

  • 19. [The responses of leukemia cells to interleukin-2 in vitro].
    Yang Y
    Hua Xi Yi Ke Da Xue Xue Bao; 1997 Jun; 28(2):188-92. PubMed ID: 10683932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant murine interleukin-12 elicits potent antileukemic immune responses in a murine model of Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Gruber TA; Skelton DC; Kohn DB
    Cancer Gene Ther; 2005 Oct; 12(10):818-24. PubMed ID: 15877085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.